Legionnaire’s Disease and Immunosuppressive Drugs
-
Tin Han Htwe [1] ; Nancy M. Khardori [1]
-
[1] Sentara Medical Group
-
- Localización: Infectious disease clinics of North America, ISSN 0891-5520, Vol. 31, Nº. 1, 2017, págs. 29-42
- Idioma: inglés
- Texto completo no disponible (Saber más ...)
-
Resumen
Immunosuppressive agents predispose patients to legionnaire’s disease. Patients receiving tumor necrosis factor antagonists are generally not severely immunocompromised by the underlying disease. In patients with malignancy receiving immunosuppressive therapies, it is difficult to balance the underlying disease versus the therapy used. Transplant recipients are often on multiple drugs, including immunosuppressants. It seems that immunosuppressive drugs add to the risk for legionella infection. The index of suspicion should be high for legionella infection early during a compatible clinical syndrome. The control of Legionella species and prevention of transmission should be the foremost goal in protecting susceptible populations from Legionnaire’s disease
